WellPoint (NYSE: WLP) reported earnings on July 25. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), WellPoint met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share expanded slightly.

Gross margins improved, operating margins increased, net margins contracted.

Revenue details
WellPoint reported revenue of $15.17 billion. The 16 analysts polled by S&P Capital IQ anticipated a top line of $15.30 billion on the same basis. GAAP reported sales were 2.0% higher than the prior-year quarter's $15.10 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $2.04. The 21 earnings estimates compiled by S&P Capital IQ anticipated $2.07 per share. GAAP EPS of $1.94 for Q2 were 2.6% higher than the prior-year quarter's $1.89 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 21.5%, 40 basis points better than the prior-year quarter. Operating margin was 7.6%, 20 basis points better than the prior-year quarter. Net margin was 4.2%, 40 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $15.44 billion. On the bottom line, the average EPS estimate is $2.00.

Next year's average estimate for revenue is $61.43 billion. The average EPS estimate is $7.76.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 924 members out of 981 rating the stock outperform, and 57 members rating it underperform. Among 285 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 277 give WellPoint a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WellPoint is outperform, with an average price target of $83.89.